Literature DB >> 22101168

Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells.

Li-xia Guo1, Zhi-ning Xia, Xue Gao, Fei Yin, Jian-hui Liu.   

Abstract

AIM: To explore the role of the glucagon-like peptide 1 receptor (GLP-1R) in geniposide regulated insulin secretion in rat INS-1 insulinoma cells.
METHODS: Rat INS-1 insulinoma cells were cultured. The content of insulin in the culture medium was measured with ELISA assay. GLP-1R gene in INS-1 cells was knocked down with shRNA interference. The level of GLP-1R protein in INS-1 cells was measured with Western blotting.
RESULTS: Geniposide (0.01-100 μmol/L) increased insulin secretion from INS-1 cells in a concentration-dependent manner. Geniposide (10 μmol/L) enhanced acute insulin secretion in response to both the low (5.5 mmol/L) and moderately high levels (11 mmol/L) of glucose. Blockade of GLP-1R with the GLP-1R antagonist exendin (9-39) (200 nmol/L) or knock-down of GLP-1R with shRNA interference in INS-1 cells decreased the effect of geniposide (10 μmol/L) on insulin secretion stimulated by glucose (5.5 mmol/L).
CONCLUSION: Geniposide increases insulin secretion through glucagon-like peptide 1 receptors in rat INS-1 insulinoma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101168      PMCID: PMC4010339          DOI: 10.1038/aps.2011.146

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  20 in total

1.  GLP-1 protects β-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop.

Authors:  Marion Cornu; Bernard Thorens
Journal:  Islets       Date:  2009 Nov-Dec       Impact factor: 2.694

2.  Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

Authors:  D Marguet; L Baggio; T Kobayashi; A M Bernard; M Pierres; P F Nielsen; U Ribel; T Watanabe; D J Drucker; N Wagtmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

Authors:  Josephine M Egan; Angela Bulotta; Hongxiang Hui; Riccardo Perfetti
Journal:  Diabetes Metab Res Rev       Date:  2003 Mar-Apr       Impact factor: 4.876

4.  Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.

Authors:  E Hartter; T Svoboda; B Ludvik; M Schuller; B Lell; E Kuenburg; M Brunnbauer; W Woloszczuk; R Prager
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 5.  Phasic insulin release and metabolic regulation in type 2 diabetes.

Authors:  Stefano Del Prato; Piero Marchetti; Riccardo C Bonadonna
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

6.  Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents.

Authors:  A M Jennings; R M Wilson; J D Ward
Journal:  Diabetes Care       Date:  1989-03       Impact factor: 19.112

7.  Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance.

Authors:  M J Davies; G Rayman; A Grenfell; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1994-06       Impact factor: 4.359

8.  Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse.

Authors:  Y Kano; T Kanatsuna; N Nakamura; Y Kitagawa; H Mori; S Kajiyama; K Nakano; M Kondo
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

9.  Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.

Authors:  S Martin; H Kolb; J Beuth; R van Leendert; B Schneider; W A Scherbaum
Journal:  Diabetologia       Date:  2003-11-05       Impact factor: 10.122

10.  The relationship between first-phase insulin secretion and glucose metabolism.

Authors:  E I Widén; J G Eriksson; A V Ekstrand; L C Groop
Journal:  Acta Endocrinol (Copenh)       Date:  1992-10
View more
  18 in total

1.  5'-AMP-activated protein kinase plays an essential role in geniposide-regulated glucose-stimulated insulin secretion in rat pancreatic INS-1 β cells.

Authors:  Yanan Hao; Chunyan Liu; Fei Yin; Yonglan Zhang; Jianhui Liu
Journal:  J Nat Med       Date:  2016-09-07       Impact factor: 2.343

2.  Geniposide accelerates proteasome degradation of Txnip to inhibit insulin secretion in pancreatic β-cells.

Authors:  C Y Liu; Y N Hao; F Yin; Y L Zhang; J H Liu
Journal:  J Endocrinol Invest       Date:  2016-12-20       Impact factor: 4.256

Review 3.  The Beneficial Effects of Geniposide on Glucose and Lipid Metabolism: A Review.

Authors:  Siting Gao; Qin Feng
Journal:  Drug Des Devel Ther       Date:  2022-09-30       Impact factor: 4.319

4.  Geniposide alleviates depression-like behavior via enhancing BDNF expression in hippocampus of streptozotocin-evoked mice.

Authors:  Junming Wang; Peili Duan; Ying Cui; Qing Li; Yanran Shi
Journal:  Metab Brain Dis       Date:  2016-06-16       Impact factor: 3.584

5.  Neuroprotective effects of geniposide in SH-SY5Y cells and primary hippocampal neurons exposed to Aβ42.

Authors:  Ping Sun; Haimin Ding; Mi Liang; Xiaojing Li; Weichuan Mo; Xu Wang; Ying Liu; Rongqiao He; Qian Hua
Journal:  Biomed Res Int       Date:  2014-11-18       Impact factor: 3.411

6.  Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.

Authors:  Lili Shi; Ye Ji; Xiaoyan Jiang; Lihong Zhou; Ying Xu; Yanbo Li; Wei Jiang; Ping Meng; Xiaomin Liu
Journal:  Cardiovasc Diabetol       Date:  2015-02-07       Impact factor: 9.951

7.  Chronic administration of anti-stroke herbal medicine TongLuoJiuNao reduces amyloidogenic processing of amyloid precursor protein in a mouse model of Alzheimer's disease.

Authors:  Ping He; Pengtao Li; Qian Hua; Yuan Liu; Matthias Staufenbiel; Rena Li; Yong Shen
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

8.  Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells.

Authors:  Jianhui Liu; Lixia Guo; Fei Yin; Yonglan Zhang; Zixuan Liu; Yanwen Wang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

9.  β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.

Authors:  Céline Gleizes; Guillaume Kreutter; Malak Abbas; Mohamad Kassem; Andrei Alexandru Constantinescu; Julie Boisramé-Helms; Blandine Yver; Florence Toti; Laurence Kessler
Journal:  J Cell Mol Med       Date:  2015-11-26       Impact factor: 5.310

10.  Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway.

Authors:  D D Yao; L Yang; Y Wang; C Liu; Y J Wei; X B Jia; W Yin; L Shu
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.